SY
Syros Pharmaceuticals, Inc.
SYRS · OTC
$0.00 +0.00% (+$0.00)
1M +300.00%
Market Cap $9.39K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
0/9Valuation
100 /100
Cheap P/S 0.00x
P/B 0.00x
P/E N/A
Growth
0 /100
Declining Rev. growth 13.01%
Book val. growth 43.12%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 77.33%
Net margin 1,656.34%
Op. margin 1,298.19%
Quality
1 /100
Poor ROIC 91.82%
ROA 97.86%
Asset turnover 0.06x
Debt
50 /100
Moderate Debt/Equity 3.73x
Current ratio 3.95x
Int. coverage -31.10x
Stability
42 /100
Moderate Beta 1.36x
Rev. volatility 52.31%
EPS volatility 13.07%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na SYRS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James E. Bradner
Employees
68
Headquarters
Cambridge
Nadcházející události
29 ŘÍJ
Earnings
Upcoming earnings report